Souvien Therapeutics

About:

Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.

Top Investors: Juvenescence

Description:

Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.

Total Funding Amount:

$3.5M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

Founders:

Number of Employees:

Last Funding Date:

2019-05-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai